Latest News
01-Mar-2024 Suven to Merge with Cohance to Create a Listed Pharma Major
01-Mar-2024 Takeda to Soon Start Trials in India for Dengue Jab
01-Mar-2024 Private Hospitals may Move SC Against Plan to Standardise Rates
28-Feb-2024 Telangana Scraps BRS’ 18k-acre Pharma City Project, Plans to Set Up Smaller Clusters Instead
28-Feb-2024 Biological E in Pact to Make Japanese Drug Co Takeda’s Dengue Vaccine
  more...
Latest Reports
Jan-24 Strong EBITDA growth aided by US markets - Prabhudas Lilladher  
Oct-23 Decoding The Fluorine Chemistry - Emkay Research  
Oct-23 Challenging times for industry - Nuvama  
Oct-23 2QFY24 Result Preview - Nirmal Bang  
Oct-23 Jul-Sep'23 Earnings Preview - Prabhudas Lilladher  
  more...

Quarterly Summary September-2023
Desc Current Previous Per.Chg
Sales 63305.5 60797.8 4.1
Otherincome 2434.9 2081.8 17.0
Expense 49099.3 48299.2 1.7
RawMaterial 19825.3 20615.2 -3.8
StaffCost 9515.8 8780.7 8.4
ExciseDuty 52.3 60.6 -13.7
OtherExp 14783.2 13820.3 7.0
Interest 1133.1 835.0 35.7
GrossProfit 16461.7 14685.6 12.1
Depreciation 2875.3 2775.6 3.6
Tax 2952.0 2899.0 1.8
NetProfit 10605.0 10161.4 4.4
Total.Comp 182 -- --
Source: ETIG Database

Sectoral Companies As on 2 Mar 2024
Company Name (Top 10) MarketCap (Rs.Crore)
Sun Pharma. 372143.43
Cipla 119738.08
Dr.Reddy's 104099.88
Zydus Life 94456.80
Divi's Lab 93065.44
Torrent Phar 91272.19
Mankind Phar 86002.81
Lupin 74435.53
Aurobindo Ph 63048.70
Alkem Labora 61077.50
Abbott (I) 59668.73
GlaxoSmith.P 36771.29
IPCA Lab. 30376.77
  click here for the complete list